ID

27854

Descripción

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01027065

Link

https://clinicaltrials.gov/show/NCT01027065

Palabras clave

Versiones (1)
  1. 1/12/17 1/12/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de diciembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Hepatitis B NCT01027065

Inglés

Eligibility Chronic Hepatitis B NCT01027065

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hbv-infected patients
Descripción

Hepatitis B, Chronic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0524909
hbeag-negative patients
Descripción

Hepatitis B e antigen negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948827
age > 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patients with active chronic hepatitis at the start of the antiviral treatment
Descripción

Hepatitis, Chronic | Antiviral Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019189
UMLS CUI [2]
C0280274
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
Descripción

Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0369332
UMLS CUI [1,2]
C3827727
UMLS CUI [2,1]
C0971023
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0384228
UMLS CUI [3,2]
C0205360
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
Descripción

entecavir | Tenofovir | Pegylated interferon alfa Acceptable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0971023
UMLS CUI [2]
C0384228
UMLS CUI [3,1]
C0907160
UMLS CUI [3,2]
C1879533
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
infection by hcv
Descripción

Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019196
infection by hiv-1 and /or hiv-2
Descripción

HIV-1 infection | HIV-2 infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2363741
UMLS CUI [2]
C0854094
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
Descripción

Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0205369
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C1708385
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019163
previous treatment by lamivudine and/or nucleosides analogues
Descripción

Lamivudine | Nucleoside Analogs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0209738
UMLS CUI [2]
C1579410
inactive carrier
Descripción

Carrier Without Activity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0560175
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0205177
cirrhosis
Descripción

Liver Cirrhosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023890
other liver disease (notably from alcoholic, metabolic or immunological origin)
Descripción

Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0023896
UMLS CUI [3,1]
C0023895
UMLS CUI [3,2]
C0015127
UMLS CUI [3,3]
C0311400
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0015127
UMLS CUI [4,3]
C0205470
history of clinical autoimmune disease or active auto-immune disease
Descripción

Autoimmune Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
type i diabetes mellitus
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
severe asthma, presently on chronic medications
Descripción

Severe asthma | Pharmaceutical Preparations chronic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0581126
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0205191
Volver a la parte superior de la página

Similar models

Eligibility Chronic Hepatitis B NCT01027065

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B, Chronic
Item
chronic hbv-infected patients
boolean
C0524909 (UMLS CUI [1])
Hepatitis B e antigen negative
Item
hbeag-negative patients
boolean
C0948827 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Hepatitis, Chronic | Antiviral Therapy
Item
patients with active chronic hepatitis at the start of the antiviral treatment
boolean
C0019189 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Hepatitis B virus DNA Undetectable | Entecavir Stable | Tenofovir Stable
Item
patient with a hbv dna undetectable (<70 copies/ml) stable for at least 3 months under entecavir or tenofovir treatment.
boolean
C0369332 (UMLS CUI [1,1])
C3827727 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0384228 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
entecavir | Tenofovir | Pegylated interferon alfa Acceptable
Item
ongoing treatment by entecavir or tenofovir at screening note: previous treatment with pegylated ifn monotherapy, before the start of entecavir or tenofovir, is acceptable
boolean
C0971023 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0907160 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C
Item
infection by hcv
boolean
C0019196 (UMLS CUI [1])
HIV-1 infection | HIV-2 infection
Item
infection by hiv-1 and /or hiv-2
boolean
C2363741 (UMLS CUI [1])
C0854094 (UMLS CUI [2])
Communicable Disease Requirement Therapeutic procedure Specific | Communicable Disease Hospitalization Required | Exception Hepatitis B
Item
apart from hbv infection, presence of active infection requiring a specific treatment or a hospitalization
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
Lamivudine | Nucleoside Analogs
Item
previous treatment by lamivudine and/or nucleosides analogues
boolean
C0209738 (UMLS CUI [1])
C1579410 (UMLS CUI [2])
Carrier Without Activity
Item
inactive carrier
boolean
C0560175 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Liver disease Other | Alcoholic Liver Diseases | Liver disease Cause Metabolic | Liver disease Cause immunological
Item
other liver disease (notably from alcoholic, metabolic or immunological origin)
boolean
C0023895 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0023896 (UMLS CUI [2])
C0023895 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0311400 (UMLS CUI [3,3])
C0023895 (UMLS CUI [4,1])
C0015127 (UMLS CUI [4,2])
C0205470 (UMLS CUI [4,3])
Autoimmune Disease
Item
history of clinical autoimmune disease or active auto-immune disease
boolean
C0004364 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Severe asthma | Pharmaceutical Preparations chronic
Item
severe asthma, presently on chronic medications
boolean
C0581126 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial